{"id":"W2019445754","doi":"10.1016/j.pupt.2011.07.006","title":"24-hour Bronchodilation following a single dose of the novel β2-agonist olodaterol in COPD","year":2011,"lang":"en","type":"article","venue":"Pulmonary Pharmacology & Therapeutics","topic":"Chronic Obstructive Pulmonary Disease (COPD) Research","field":"Medicine","cited_by":60,"is_retracted":false,"has_abstract":false,"ca_institutions":"Boehringer Ingelheim (Canada)","funders":"","keywords":"Bronchodilation; Medicine; Pharmacokinetics; Indacaterol; Tolerability; Bronchodilator; Anesthesia; Placebo; COPD; Spirometry; Crossover study; Inhaler; Pharmacology; Adverse effect; Internal medicine; Asthma","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0003979404,0.0003272373,0.0004938868,0.0002397272,0.0001579365,0.00001106799,0.0004785782,0.0002243945,0.0005499011],"category_scores_gemma":[0.00001122848,0.0002686535,0.000308022,0.0006052644,0.0004877518,0.0001936618,0.0002588335,0.0006735115,0.00003270025],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005117047,"about_ca_system_score_gemma":0.0003955479,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00011377,"about_ca_topic_score_gemma":0.00002783466,"domain_scores_codex":[0.9974447,0.0002868159,0.0005974512,0.0005107844,0.0004807836,0.0006794803],"domain_scores_gemma":[0.9987884,0.0001578121,0.0002236918,0.0005158124,0.0001371897,0.0001770693],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","study_design_scores_codex":[0.001990505,0.00348993,0.1997306,0.000192986,0.0004205439,0.0002688658,0.001061337,0.00002853245,0.7717935,0.00003959631,0.0001253006,0.0208583],"study_design_scores_gemma":[0.00616938,0.0003493094,0.8779993,0.000136716,0.001258994,0.0002061621,0.0005145407,0.006169067,0.09173862,0.0003836463,0.01467326,0.0004009912],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.989627,0.00185061,0.0000952843,0.001669405,0.001200164,0.001436042,0.00005193066,0.00006619163,0.004003368],"genre_scores_gemma":[0.9961113,0.0001132029,0.0004159104,0.002323662,0.0001918494,0.00009998243,0.00003132434,0.00007280002,0.0006399767],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.6800549,"threshold_uncertainty_score":0.9999766,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.07730351345816831,"score_gpt":0.3302268691855251,"score_spread":0.2529233557273568,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}